Profile | GDS4284 / 209162_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1367.92 | 79 |
GSM687648 | Patient 402 control | 1256.67 | 77 |
GSM687653 | Patient 403 control | 1593.06 | 81 |
GSM687658 | Patient 404 control | 1028.31 | 74 |
GSM687663 | Patient 411 control | 1577.56 | 81 |
GSM687668 | Patient 422 control | 1808.25 | 82 |
GSM687673 | Patient 424 control | 1369.15 | 78 |
GSM687678 | Patient 425 control | 1337.29 | 78 |
GSM687683 | Patient 427 control | 1080.28 | 75 |
GSM687688 | Patient 428 control | 1509.67 | 80 |
GSM687695 | Patient 441 control | 601.607 | 65 |
GSM687699 | Patient 443 control | 1368.23 | 79 |
GSM687704 | Patient 444 control | 1285.62 | 78 |
GSM687707 | Patient 448 control | 1720.92 | 82 |
GSM687712 | Patient 449 control | 1284.74 | 78 |
GSM687719 | Patient 450 control | 1255.14 | 77 |
GSM687724 | Patient 451 control | 1306.91 | 78 |
GSM687728 | Patient 452 control | 1051.81 | 75 |
GSM687646 | Patient 401 treated 24h | 1529.89 | 80 |
GSM687649 | Patient 402 treated 24h | 1452.45 | 79 |
GSM687665 | Patient 411 treated 24h | 1452.97 | 80 |
GSM687651 | Patient 402 treated 4 weeks | 1676.49 | 81 |
GSM687667 | Patient 411 treated 4 weeks | 1647.71 | 81 |
GSM687670 | Patient 422 treated 24h | 1682.99 | 81 |
GSM687671 | Patient 422 treated 4 weeks | 1611.92 | 81 |
GSM687654 | Patient 403 treated 24h | 1432.13 | 79 |
GSM687675 | Patient 424 treated 24h | 1428.65 | 79 |
GSM687685 | Patient 427 treated 24h | 1373.1 | 79 |
GSM687656 | Patient 403 treated 4 weeks | 1751.13 | 82 |
GSM687677 | Patient 424 treated 4 weeks | 1652.14 | 81 |
GSM687687 | Patient 427 treated 4 weeks | 1662.87 | 81 |
GSM687692 | Patient 428 treated 4h | 839.507 | 71 |
GSM687716 | Patient 449 treated 4h | 1214.85 | 77 |
GSM687722 | Patient 450 treated 4h | 863.312 | 72 |
GSM687680 | Patient 425 treated 24h | 1299.31 | 78 |
GSM687690 | Patient 428 treated 24h | 700.514 | 69 |
GSM687700 | Patient 443 treated 24h | 1347.91 | 78 |
GSM687705 | Patient 444 treated 24h | 1361.02 | 79 |
GSM687714 | Patient 449 treated 24h | 804.082 | 71 |
GSM687721 | Patient 450 treated 24h | 754.061 | 69 |
GSM687682 | Patient 425 treated 4 weeks | 1110.36 | 76 |
GSM687694 | Patient 428 treated 4 weeks | 1197.47 | 76 |
GSM687702 | Patient 443 treated 4 weeks | 1283.15 | 77 |
GSM687718 | Patient 449 treated 4 weeks | 1125.71 | 76 |
GSM687723 | Patient 450 treated 4 weeks | 942.187 | 73 |
GSM687661 | Patient 404 treated 4h | 960.59 | 73 |
GSM687710 | Patient 448 treated 4h | 1942.16 | 84 |
GSM687726 | Patient 451 treated 4h | 1529.24 | 80 |
GSM687730 | Patient 452 treated 4h | 86.3846 | 20 |
GSM687660 | Patient 404 treated 24h | 601.296 | 67 |
GSM687697 | Patient 441 treated 24h | 1217.7 | 78 |
GSM687709 | Patient 448 treated 24h | 2079.4 | 85 |
GSM687725 | Patient 451 treated 24h | 1484.27 | 80 |
GSM687729 | Patient 452 treated 24h | 963.835 | 75 |
GSM687727 | Patient 451 treated 4 weeks | 1439.34 | 79 |
GSM687731 | Patient 452 treated 4 weeks | 1537.36 | 80 |